FH-/- CL 1 Cell Line
Invented at Cancer Research UK Glasgow: The Beatson Institute
- Datasheet
- References (4)
- Inventor Info
Info
Catalogue Number | 153289 |
Antigen/Gene or Protein Targets | Fumarate Hydratase |
Synonyms | Fumarate hydratase, FH, fumarase, Fh1, Hereditary leiomyomatosis and renal cell cancer, HLRCC |
Host | Mouse |
Tissue | Kidney |
Disease Keywords | Cancer |
Model | Knock-Out |
Relevance | Fumarate hydratase – which can be found in either a mitochondrial or cytosolic form - is an enzyme that catalyzes the reversible hydration and dehydration of fumarate to malate. Signal sequences located in the protein dictate the subcellular location of each FH isoenzyme. The cytosolic form is involved in the metabolism of amino acids and fumarate and the mitochondrial form is involved in the Krebs Cycle (tricarboxylic acid cycle or the citric acid cycle). Germline mutations of FH are responsible for hereditary leiomyomatosis and renal-cell cancer (HLRCC)1. |
Conditional | No |
Research Area | Cancer, Drug Discovery & Development, Metabolism |
Recommended Growing Conditions | Cells can be maintained in DMEM supplemented with 10% FBS, 2 mmol/l glutamine, 1 mmol/l pyruvate and 50 mg/l uridine. However, the inventor advises to use more physiological conditions for experiments, such as Plasmax, available on our website. |
Cellosaurus ID | CVCL_HG01 |
References: 4 entries
Frezza et al. 2011. Nature. 477(7363):225-8. PMID: 21849978.
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
Europe PMC ID: 21849978
Pollard et al. 2007. Cancer Cell. 11(4):311-9. PMID: 17418408.
Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway.
Europe PMC ID: 17418408
Add a reference
References: 4 entries
Frezza et al. 2011. Nature. 477(7363):225-8. PMID: 21849978.
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
Pollard et al. 2007. Cancer Cell. 11(4):311-9. PMID: 17418408.
Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway.
Add a reference